Feed Insights Top Reports Pricing

⌘K

16:08:49·4h

SECFilingvia Quantisnow

SEC Form DEFA14A filed by SCYNEXIS Inc.

ByQuantisnow·Wall Street's wire, on your screen.

SCYX· SCYNEXIS Inc.

Health Care

Original source

This insight was delivered by Quantisnow - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SCYX (SCYNEXIS Inc.) and more on Quantisnow.

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

SCYX
SCYNEXIS Inc.
Health Care

Related

SEC4h
SEC Form DEF 14A filed by SCYNEXIS Inc.
SEC3d
SEC Form DEF 14A filed by SCYNEXIS Inc.
SEC10d
SEC Form PRE 14A filed by SCYNEXIS Inc.
SEC10d
SCYNEXIS Inc. filed SEC Form 8-K: Leadership Update
SEC13d
SEC Form PRE 14A filed by SCYNEXIS Inc.
INSIDER28d
SEC Form 4 filed by Angulo Gonzalez David
SEC30d
SCYNEXIS Inc. filed SEC Form 8-K: Regulation FD Disclosure
PR30d
Poxel Announces the Sale of PXL770 to Scynexis for a Total Amount of up to $196 Million

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds Follow on Google News

Top lists

Trending By market cap Active companies Insider purchases FDA approvals Short volume screener Sectors Market reports

Browse

By event category By exchange Earnings calendar Dividend tracker Insider tracker IPO calendar Compare stocks

Publish

Publish an article Amend a newsitem Pricing Guidelines Terms

Company

About Pricing Refer a trader25%Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022